NCT02526225View on ClinicalTrials.gov

A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke.

PHASE2CompletedINTERVENTIONAL
Enrollment

3,452

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

May 1, 2018

Study Completion Date

August 31, 2019

Conditions
Ischemic Stroke
Interventions
DRUG

Ginkgo diterpene lactone meglumine injection

5 ml/times, 1 time/day.Before use, the drug slowly added to the 0.9% sodium chloride injection diluted in 250 ml, slow intravenous drip.

DRUG

Ginkgo diterpene lactone meglumine injection simulation

5 ml/times, 1 time/day.Before use, the drug slowly added to the 0.9% sodium chloride injection diluted in 250 ml, slow intravenous drip.

Trial Locations (1)

100050

Tiantan Hospital, Beijing

All Listed Sponsors
collaborator

Beijing Bionovo Medicine Development Co., Ltd.

OTHER

lead

Beijing Tiantan Hospital

OTHER

NCT02526225 - A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke. | Biotech Hunter | Biotech Hunter